Photdynamic Therapy (PDT)

PreclinicalSmall molecule

RRoswell Park Cancer Institute

Photdynamic Therapy (PDT) is one of 12 small molecule programs targeting Recurrent. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

RecurrentTerminated

RecurrentPreclinical

Terminated

Competition

Competitive Landscape

12 competitors in Recurrent

#DrugCompanyPhaseTrials

Xiaflex

GGrupo Espanol de Tumores Neuroendocrinos

Approved

1 2

Certolizumab

Johnson & Johnson

Phase 3

1 3

Opdivo

Bristol-Myers Squibb

Phase 2

2 4

Yervoy

Bristol-Myers Squibb

Phase 1

1 5

Lu-PSMA I&T

MMedical University of Vienna

Phase 2

1 6

Anti-PD-1 Monoclonal Antibody

IiTeos Therapeutics

Phase 1

1 7

Photofrin

PPinnacle Biologics Inc.

Preclinical

1 8

Cordarone

WWyeth-Lederle Vaccines

Preclinical

1 9

Ptvg-HP

UUniversity of Wisconsin, Madison

Phase 1

1 10

MBG453

Novartis

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Recurrent1 trial

Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat

Terminated·RRoswell Park Cancer Institute·N/A·NCT00530088·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Photdynamic Therapy (PDT). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Photdynamic Therapy (PDT) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Photdynamic Therapy (PDT). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Roswell Park Cancer Institute company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: RRoswell Park Cancer Institute

Photdynamic Therapy (PDT)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Recurrent1 trial

References

Drug Info

Quick Facts

Related News